Zopilone

Quick links to important sections

Zopilone

Method of action: Hypnotic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zopilone

Quick Facts

Property Description
Active ingredient Eszopiclone
Form Oral film-coated tablets
Pharmacological class Sedative-hypnotic agent, Z-drug
General purpose Supports sleep onset and maintenance
Origin Synthetic organic compound (S-isomer)

Defining Zopilone: Composition, Origin, and Class

Zopilone is a synthetic prescription drug whose active ingredient, Eszopiclone, is formally classified as a nonbenzodiazepine hypnotic agent belonging to the cyclopyrrolone class. This compound addresses neurological activity related to wakefulness. This medication is defined chemically as a pyrrolopyrazine derivative and represents the isolated S-isomer of the older racemic mixture, zopiclone, providing a targeted action profile.

The pharmaceutical agent is prepared as a single-ingredient product for oral administration, typically formulated into film-coated tablets. This presentation ensures the precise delivery of the active Eszopiclone compound. It is commonly grouped as a Z-drug, a term clinically recognized for newer hypnotic agents that offer an alternative to traditional benzodiazepines, emphasizing its refined chemical composition.

Pharmacological Classification and General Purpose

Zopilone is a sedative-hypnotic agent intended to manage difficulties associated with sleep by slowing activity in the central nervous system (CNS). The fundamental action involves the drug functioning as a positive allosteric modulator that interacts with the GABAA receptor complex in the brain, thereby enhancing the effects of the inhibitory neurotransmitter GABA.

This specific interaction reduces overall neuronal brain excitability, which facilitates the transition to sleep. The general therapeutic purpose of Zopilone is to address both sleep onset latency (difficulty falling asleep) and the maintenance of sleep continuity, a typical use scenario for individuals experiencing persistent insomnia. The drug’s action is focused on supporting the sleep cycle in adults.

What side effects are possible with Zopilone?

Possible Side Effects and Safety Information

The safety profile for Eszopiclone (Zopilone) is officially organized by regulatory authorities based on the frequency and the physiological system affected. The most frequently documented adverse reaction is taste perversion (dysgeusia), which is classified as very common. Other commonly reported effects include headache, somnolence (drowsiness), dizziness, and dry mouth.

Adverse reactions are formally grouped into System-Organ Classes. Effects on the Nervous System include somnolence and amnesia, while Gastrointestinal Disorders include nausea and dry mouth. Less common Psychiatric Disorders such as hallucinations and anxiety have also been documented.


Serious Adverse Reactions and Key Safety Constraints

The official label documents specific serious adverse reactions. These include a warning regarding complex sleep-related behaviors, such as sleep-walking or sleep-driving, which may result in serious injury. Additionally, severe hypersensitivity reactions like angioedema and the worsening of depression and suicidal ideation are noted.

Safety is also assessed in relation to duration and population. The risk of developing dependence and withdrawal symptoms increases with prolonged use, linking the risk profile to the duration of exposure. Specific considerations apply to older adults, who face an increased risk of next-day impairment and falls. Patients with severe hepatic impairment are often noted as a contraindication or population requiring specific caution, defining a clear safety limitation of the medicine.

Overdose and Emergency Response

Zopilone Overdose and when to seek help

The regulatory classification of Zopilone (Eszopiclone) overdose is based on the presentation of exaggerated central nervous system (CNS) depressant effects. Documented overdose manifestations include profound somnolence, staggering, and clinically relevant mental status changes. Symptoms may also involve severe nausea and severe vomiting. The overdose profile is characterized by escalation to serious, life-threatening outcomes, such as respiratory depression, loss of consciousness leading to coma, and death. This risk of severe outcomes is significantly increased when Zopilone is co-ingested with alcohol or other CNS depressant medications. To mitigate this risk, prescribers are officially directed to dispense the least number of tablets feasible to patients at risk of intentional overdose.

Immediate Emergency Actions

Official guidance requires that emergency medical attention be sought immediately for any suspected overdose. Individuals must contact the local Poison Help line. During patient management, the possibility of an overdose involving multiple drugs must always be considered.

Overdose Management

Treatment is defined by regulatory bodies as primarily symptomatic and supportive. This involves continuous and close monitoring of vital signs, including respiratory and cardiovascular functions. Procedural support measures, such as gastric lavage or the administration of activated charcoal, may be utilized if performed soon after ingestion. While supportive care is primary, the use of the GABA A receptor antagonist Flumazenil may be considered in a clinical setting.

Therapeutic Uses of Zopilone

Zopilone's Main Uses and Therapeutic Benefits

Zopilone is generally used in situations involving certain distressing symptoms where short-term symptomatic assistance is needed. This medicine is primarily applied in clinical settings that involve acute or unstable symptom patterns. The medication may be applied in contexts involving symptoms of difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings due to transient or short-term insomnia.

The application of this medication is considered relevant to assist with functional stability and day-to-day comfort. The medicine is commonly used across conditions characterized by periods of heightened symptoms or those involving episodic or fluctuating manifestations. It contributes to easing the overall symptom load by providing temporary assistance in symptom stabilization, assisting with maintaining functional stability when symptoms become temporarily overwhelming.

Quick Fact: Relief for Symptoms that interfere with daily functioning

Eligibility and Restrictions for Use

Zopilone (Eszopiclone) is restricted to the adult population and is subject to strict eligibility rules defined by government regulatory authorities. Use is contraindicated in several specific populations, meaning the medicine must not be used.

Absolute Contraindications (Prohibited Use)

Contraindicated Population Regulatory Basis
Known hypersensitivity to Eszopiclone, Zopiclone, or components. Absolute exclusion
History of complex sleep behaviors (e.g., sleep-driving) after taking a Z-drug. Absolute exclusion
Patients with severe respiratory insufficiency or Myasthenia Gravis. Exclusion due to potential exacerbation
Patients with severe hepatic impairment. Exclusion due to systemic exposure risks

Age and Physiological Restrictions

  • Pediatric Use: Use in children and adolescents under 18 years is not recommended because safety and effectiveness have not been established in this age group.
  • Older Adults (Geriatric): Use is permitted but involves restricted maximum dosage due to increased sensitivity and risk of adverse effects compared to younger adults.
  • Pregnancy and Lactation: Use during pregnancy and by breastfeeding mothers is generally not recommended, as regulatory documents advise caution regarding potential risk to the newborn.

What should I know about interactions with other medicines?

Zopilone can interact with numerous other medications and substances, primarily by increasing central nervous system (CNS) depressant effects or altering Zopilone's metabolism.

Increased Sedation Risk

Concomitant use of Zopilone with other CNS depressants significantly increases the risk of excessive drowsiness, respiratory depression, coma, and even death. This combination should be reserved only for patients for whom alternative treatment options are inadequate, requiring the lowest effective dosages and close monitoring. Categories of interacting CNS depressants include:

  • Opioids and Narcotic Analgesics (e.g., codeine, morphine)
  • Antipsychotics and Anxiolytics
  • Other Hypnotics/Sedatives (including other z-drugs or benzodiazepines)
  • Antidepressant Agents
  • Anticonvulsants
  • Sedating Antihistamines

Alcohol must be strictly avoided due to its additive CNS depressant effects, which severely impair coordination and increase the risk of adverse outcomes.


Metabolic Interactions

Zopilone is primarily metabolized by the cytochrome P450 enzyme CYP3A4. Medications that inhibit or induce this enzyme can change Zopilone's plasma concentrations:

Interaction Type Examples of Interacting Medicines Effect on Zopilone's Activity
CYP3A4 Inhibitors Clarithromycin, Erythromycin, Ketoconazole, Ritonavir Increases Zopilone concentration, enhancing its effects.
CYP3A4 Inducers Rifampicin, Carbamazepine, Phenytoin, St. John's Wort Decreases Zopilone concentration, reducing its effectiveness.

Patients should inform their healthcare provider of all prescription, over-the-counter, and herbal supplements they are taking to manage potential interactions.

Mechanism of Action

The action of Zopilone centers on potentiating GABAergic neurotransmission, directly influencing neural pathways modulating arousal states.

Amplification of GABAergic Inhibition

Zopilone acts as a Positive Allosteric Modulator (PAM) by binding to the GABAA receptor complex, the primary target for the inhibitory neurotransmitter, GABA. This modulation increases GABA's effectiveness, primarily by prolonging the duration that the receptor's chloride ion channel remains open. This action enhances the inhibitory drive within the central nervous system (CNS), increasing the threshold for neuronal excitation.

Neuronal Hyperpolarization and CNS Dampening

The extended opening of the channel facilitates a sustained influx of negatively charged chloride ions (Cl^-) into the neuron. This movement causes neuronal hyperpolarization, electrically suppressing the neuron's ability to transmit signals. This effect is specifically exerted on key circuits within the reticular activating system (RAS) that promote arousal. The resulting physiological consequence is a reduction in overall neuronal excitability, which functionally guides the CNS toward decreased arousal signaling.

Mechanism Limitation by Absorption

The mechanism's effectiveness is constrained by factors influencing the rate of concentration attainment at receptor sites. Delayed gastrointestinal absorption can reduce the peak concentration of Eszopiclone available at the GABAA receptors during the initial time window. This slows the onset of the inhibitory physiological cascade, thereby limiting the mechanism's ability to rapidly induce CNS dampening.

Dosage and Administration Information

Zopilone is administered exclusively by the oral route in the form of a film-coated tablet, available in 1 mg, 2 mg, and 3 mg strengths. The administration regimen is strictly once daily, and the tablet must be taken immediately before bedtime when the patient is ready to initiate sleep. This scheduling requires the individual to commit to a full seven to eight hours of time remaining for uninterrupted sleep. The tablet must be swallowed whole and should not be crushed, broken, or chewed.


Official Dosing and Contextual Conditions

Standard usage guidelines stipulate that the lowest effective dose should be used, with the total daily dose for non-elderly adults not exceeding 3 mg. Administration is also conditioned by nutrition: the drug should not be taken with or immediately following a heavy, high-fat meal, as this slows drug absorption and can diminish the effect on sleep onset.

Established protocols define specific maximum doses for certain populations. For older adults (geriatric) and individuals with severe hepatic impairment, the maximum dose is restricted to 2 mg per day. A maximum dose of 2 mg also applies when the medicine is used concurrently with potent CYP3A4 inhibitors. Dosing recommendations regarding duration may vary; usage may be limited to the minimum time necessary, such as not exceeding four weeks, though the medicine is also applied for longer-term treatment in some clinical contexts. If symptoms of sleeplessness persist after 7 to 10 days of adherence to the regimen, the use protocol requires re-evaluation.

Recent Clinical Evidence

Research evidence / Overview of Studies for Zopilone (Eszopiclone)

Evidence for Primary Chronic Insomnia

The core evidence supporting the study of Zopilone relies primarily on randomized, placebo-controlled clinical trials, a design type commonly used in drug evaluation. These studies were conducted during periods of heightened symptom activity related to long-term difficulty falling asleep and staying asleep. Researchers examined sleep parameters using both objective, lab-based measurements and patient-reported outcomes describing perceived discomfort and sleep quality.

Research has explored outcomes related to the time it takes to fall asleep and the amount of time spent awake during the night. Studies monitored these core sleep endpoints across short-term periods (a few weeks) and intermediate-term periods, with key studies extending up to six months of observation against a placebo. Findings describe patterns observed in the studies where the measured sleep parameters for participants receiving the compound differed compared to those receiving the placebo.

What remains uncertain is the durability of the measured sleep patterns over very long periods. Follow-up durations were limited beyond the six-month controlled observation period, meaning the long-term effects are not fully established. Most of the pivotal research was associated with industry funding.


Evidence in Specific Patient Groups

Research in Older Adults

Dedicated clinical trials were evaluated in older adults, specifically individuals aged 65 and older with chronic insomnia. These studies were conducted during periods of heightened symptom activity, typically lasting up to twelve weeks. Researchers examined subjective and objective sleep outcomes, and findings describe patterns observed in the studies related to measured sleep parameters. Results apply only to the populations studied.

Research in Children and Adolescents

Research was studied for Zopilone's use in children and adolescents (aged 6 to 17 years). However, data show patterns related to sleep outcomes that were not sufficient for the compound's intended use in this age group. Regulatory bodies have noted the absence of established efficacy in this population, and data for this group remain insufficient.


What is Still Uncertain About Zopilone Research

Research highlights what is known and what is still uncertain. The evidence supporting functional outcomes, such as next-day alertness, is limited because findings were mixed or showed high variability across different trials. Comparative evidence is lacking for how Zopilone performs against all other available sleep medications in dedicated, large-scale controlled trials. Data for certain groups remain insufficient, particularly for patients with severe medical comorbidities. This means that research does not guarantee whether an individual outside the studied group will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Zopilone (FAQ)

Q: Is Zopilone the same kind of drug as Ambien or Lunesta?

Zopilone's active ingredient, Eszopiclone, is classified as a nonbenzodiazepine hypnotic agent, commonly known as a Z-drug. This classification groups it with newer hypnotic agents that offer an alternative approach compared to traditional benzodiazepines.

Q: Why do doctors prescribe Zopilone for sleep problems?

The general therapeutic purpose of Zopilone is officially defined as managing difficulties associated with persistent insomnia. This is accomplished by addressing both the time it takes an individual to fall asleep (sleep onset latency) and the ability to maintain sleep continuity throughout the night.

Q: Does Zopilone cause a metallic taste in the mouth?

According to official safety documents, the most frequently documented adverse reaction is taste perversion, which is often described by patients as a bitter or metallic taste. This effect is classified as very common.

Q: Can Zopilone be addictive if used for a long time?

Official safety information notes that the risk of developing dependence and experiencing withdrawal symptoms is linked to the duration of exposure. This risk increases with prolonged use of the medication.

Q: How quickly does Zopilone start to work after you take it?

The drug is intended to be taken immediately before bedtime when the patient is ready to initiate sleep. Regulatory documents note that the drug's absorption is critical, as delayed absorption—such as taking it with a heavy meal—can slow the onset of the effect intended to induce sleep.

Q: Can Zopilone affect my driving ability the next morning?

Official safety documents indicate concerns about next-day impairment, which can affect activities that require full alertness, such as driving. Specific considerations apply to older adults who face an increased risk of such impairment and falls.

Q: Are there any common over-the-counter pain relievers that interact with Zopilone?

Concomitant use of Zopilone with other CNS depressants significantly increases the risk of excessive drowsiness and impaired coordination. This category includes certain over-the-counter medicines, such as sedating antihistamines.

Q: Does taking Zopilone mean I will definitely stop waking up in the middle of the night?

The drug's therapeutic purpose is to support the maintenance of sleep continuity. Research findings describe patterns where the measured sleep parameters for participants differed compared to placebo, but the official data does not guarantee that any individual will respond in a specific way.

Q: What is the difference between Zopilone and benzodiazepines?

Zopilone is classified as a nonbenzodiazepine hypnotic agent and is a Z-drug. Its mechanism involves acting as a Positive Allosteric Modulator that enhances inhibitory drive by prolonging the opening time of the GABAA receptor's chloride channel. This makes it chemically and functionally distinct from traditional benzodiazepines.

Q: Are there any foods or drinks that should be avoided when taking Zopilone?

Official dosing guidelines state that the medicine should not be taken with or immediately following a heavy, high-fat meal. Official guidance states that alcohol must be strictly avoided due to its additive depressant effects on the central nervous system.

Q: Can Zopilone make anxiety worse in some people?

Official safety information lists certain mental health changes as documented adverse reactions. Anxiety is one of the less common Psychiatric Disorders that has been documented in regulatory label documents.

Q: What happens if I suddenly stop taking Zopilone?

The risk of developing dependence and experiencing withdrawal symptoms is noted to increase with prolonged use of the medication. Any changes to the medication regimen should be managed in consultation with a healthcare professional.

Q: Is Zopilone approved for treating sleep problems other than insomnia?

The general therapeutic purpose of Zopilone is officially defined as managing difficulties associated with persistent insomnia. This definition specifically covers issues related to both falling asleep and staying asleep.

Q: What should I know about Zopilone if I am a woman who might become pregnant?

Regulatory documents advise caution regarding potential risk to the newborn. Consequently, use during pregnancy is generally not recommended by official sources.

Q: Can Zopilone cause dizziness or lightheadedness?

Dizziness is officially documented as a commonly reported effect of the medication. This is an effect on the central nervous system that may be experienced by patients.

Q: What is the risk of having a serious allergic reaction to Zopilone?

Official label documents note that severe hypersensitivity reactions like angioedema are specific serious adverse reactions. Known hypersensitivity to the active ingredient or its components is an absolute contraindication for use.

Q: Is it normal to feel drowsy or 'hungover' the day after taking Zopilone?

Somnolence (drowsiness) and dizziness are officially documented as commonly reported effects of the medicine. These effects indicate potential residual sedation the day following administration.

Q: What is the relationship between Zopilone and rebound insomnia?

The risk of developing dependence and experiencing withdrawal symptoms is noted to increase with prolonged use of the medication. Rebound insomnia is often considered a type of withdrawal symptom.

Q: Are any long-term side effects described in the manufacturer's information?

The risk of developing dependence and withdrawal symptoms increases with prolonged use. Research highlights that clinical follow-up durations were limited beyond the six-month controlled observation period, meaning the long-term effects of use over very long periods are not fully established.

Q: What is the official guidance on taking Zopilone after a fatty meal?

The drug should not be taken with or immediately following a heavy, high-fat meal. Official guidance explains that this action slows drug absorption and can diminish the effect on sleep onset.

Q: Does the evidence show Zopilone helps with difficulty falling asleep or staying asleep?

Research has explored outcomes related to the time it takes to fall asleep (sleep onset latency) and the amount of time spent awake during the night (sleep maintenance). Studies monitored these core sleep endpoints across various periods against a placebo.

Q: Can Zopilone cause confusion or memory problems?

Effects on the Nervous System that have been documented include somnolence and amnesia (memory problems). Serious adverse reactions can also involve complex sleep-related behaviors, which may be associated with memory disturbances.

Q: Is Zopilone known to interact with grapefruit or grapefruit juice?

Zopilone is primarily metabolized by the CYP3A4 enzyme. Substances that inhibit this enzyme can increase the concentration of Zopilone in the body and enhance its effects. Grapefruit is known to be a strong inhibitor of the CYP3A4 enzyme.

Q: What research is available on the safety of Zopilone in breastfeeding women?

Use by breastfeeding mothers is generally not recommended. Regulatory documents advise caution regarding potential risk to the newborn based on available data.

Q: Why do some people say Zopilone causes temporary amnesia?

Amnesia is officially documented as an effect on the Nervous System. The official label documents specific serious adverse reactions, including complex sleep-related behaviors, which may be associated with temporary memory disturbances.

Q: Does Zopilone have a Boxed Warning in the official FDA documents?

Official label documents detail specific serious adverse reactions and key safety constraints. These include warnings about complex sleep-related behaviors (such as sleep-walking) and the worsening of depression and suicidal ideation.

How should Zopilone be stored and disposed of?

Storage and Disposal of Zopilone

Storage Requirements

Zopilone (Eszopiclone) tablets must be stored at Controlled Room Temperature, which is officially defined as 20 °C to 25 °C (68 °F to 77 °F). The medication must be protected from excess heat, moisture, and direct light, and it should never be frozen. To maintain its integrity and safety, Zopilone must be kept in the original container, which should be tightly closed and secured.

️ Child Safety and Security

As a controlled substance, Zopilone must be stored in a safe place to prevent theft and misuse. It is required to be kept out of the sight and reach of children, and safety caps must always be locked.

️ Disposal Instructions

Do not use the medicine after the expiration date. The preferred disposal method for unused or expired Zopilone is an authorized drug take-back program. If a take-back program is unavailable, official guidelines permit disposal in the household trash by mixing the tablets with an undesirable substance (e.g., dirt) and sealing the mixture in a separate container. Zopilone is not on the official list of medicines recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zopilone found in:

A-Z Index: